Dompé farmaceutici S.p.A. is an Italian pharmaceutical company with an organizational structure distributed across several operational sites and characterized by strong integration among corporate functions, manufacturing activities, and R&D organization. In Milan are located the Group headquarters, General Management, the Presidency, and the main staff and cross-functional support units, including Global Development, Regulatory Affairs, Pharmacovigilance, Intellectual Property, Finance, and Legal, together with the operational departments in the biotech and pharmaceutical commercial areas; the L’Aquila site is the company’s main industrial hub and hosts both manufacturing and a significant part of R&D activities, as well as logistics and administrative functions; the Naples site is dedicated to research laboratories, with a focus on drug discovery, research & early development, and R&D technologies, including the Exscalate platform. Dompé’s scientific organization is based on highly specialized and integrated platforms, including Exscalate for the rational design of new drugs through HPC and AI, Research & Early Development for the synthesis and preclinical characterization of molecules, R&D Technology for innovative formulations and delivery devices, R&D Analytical and Biotech Process Development for biotechnological and analytical development, and Global Clinical Development for clinical studies management. This structure enables Dompé to oversee the entire innovation value chain internally, from drug discovery to clinical development and manufacturing.